A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. uri icon

authors

  • Salloway, S
  • van Dyck, C H
  • Mulnard, R
  • Barakos, J
  • Gregg, K M
  • Liu, E
  • Lieberburg, I
  • Schenk, D
  • Black, R
  • Grundman, M
  • Reisa Sperling, MD
  • Gilman, S
  • Fox, N C
  • Blennow, K
  • Raskind, M
  • Sabbagh, M
  • Honig, L S
  • Doody, R

publication date

  • January 1, 2009